Geneva, Nov. 3 -- International Clinical Trials Registry received information related to the study (NCT07220876) titled 'Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma' on Oct. 22.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Avisi Technologies Inc.
Condition:
Open Angle Glaucoma (OAG)
Intervention:
Device: VisiPlate Glaucoma Implant
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: November 3, 2025
Target Sample Size: 165
Countries of Recruitment:
United States
South Africa
United States
To know more, visit https:...